iCeutica's proprietary SoluMatrix Fine Particle Technology™ creates new drugs with improved efficacy, better side effect profiles and more convenient dosing.
iCeutica is advancing a pipeline of product candidates that address broad indications, including pain and inflammation, oncology, and respiratory diseases.
Technology that fuels new product development by enabling meaningful clinical benefits and creating new intellectual property protection.